Zhejiang Jolly Pharmaceutical Co.,LTD Financials

Market Capitalization CN¥11.68 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	22.50
Forward PE	17.34
Price to Sales TTM	CN¥4.63
Price to Book MRQ	CN¥4.40
Enterprise to Revenue	4.39
Enterprise to EBITDA	16.89

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	20.52%
Operating Margin	26.32%
Return on Assets TTM	9.99%
Return on Equity TTM	19.63%

Income Statement

Revenue TTM	CN¥2,522,372,608
Revenue per Share TTM	CN¥3.63
Quarterly Revenue Growth	36.00%
Gross Profit TTM	CN¥1,329,098,805
EBITDA	CN¥627,009,940
Net Income to Common TTM	CN¥517,551,040
Diluted EPS TTM	CN¥0.74
Quarterly Earnings Growth YoY	40.60%

Balance Sheet

Total Cash MRQ	CN¥786,309,568
Total Cash per Share MRQ	CN¥1.15
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	15.10
Current Ratio MRQ	1.93
Book Value per Share MRQ	CN¥3.79

Cash Flow

Operating Cash Flow TTM	CN¥278,634,912
Levered Free Cash Flow TTM	CN¥-11,320,926

300181 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	701,387,008
Float Shares	491,370,566
Avg 10 Volume	12,990,447
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	24.74%
% Held by Institutions	26.14%

Stock Price Summary

Beta	0.12
Fifty Two Week Low	CN¥8.36
Fifty Two Week High	CN¥18.50
Fifty Two Week Change	31.55%
Day 50 MA	CN¥16.47
Day 200 MA	CN¥14.58

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.80
Forward Annual Dividend Yield	12.21%
Trailing Annual Dividend Rate	CN¥0.45
Trailing Annual Dividend Yield	3.05%
Payout Ratio	60.58%
Dividend Date
Ex Dividend Date	2024-05-22
Last Split Factor
Last Split Date	2015-05-20